{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T08:03:27Z","timestamp":1780905807977,"version":"3.54.1"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.preghy.2026.101461","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T08:58:06Z","timestamp":1774515486000},"page":"101461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comparison of oral amlodipine with oral labetalol in achieving blood pressure control in women with postpartum hypertension \u2013 A randomised control study"],"prefix":"10.1016","volume":"44","author":[{"given":"Mrinalini","family":"Kannan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.Sajeetha","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Murugesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.preghy.2026.101461_b0005","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ajog.2011.09.002","article-title":"Etiology and management of postpartum hypertension-preeclampsia","volume":"206","author":"Sibai","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2026.101461_b0010","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1701-2163(15)30588-0","article-title":"Canadian Hypertensive Disorders of Pregnancy Working Group. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary","volume":"36","author":"Magee","year":"2014","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.preghy.2026.101461_b0015","first-page":"147","article-title":"Prevalence and risk factors associated with hypertension among adults in a rural setting: the case of Ombe","volume":"34","author":"Princewel","year":"2019","journal-title":"Cameroon. Pan Afr Med J"},{"key":"10.1016\/j.preghy.2026.101461_b0020","first-page":"99","article-title":"Non-Obstetric Complications in Preeclampsia","volume":"18","author":"Pankiewicz","year":"2019","journal-title":"Prz Menopauzalny"},{"key":"10.1016\/j.preghy.2026.101461_b0025","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1161\/HYP.0000000000000208","article-title":"Hypertension in pregnancy: Diagnosis, blood pressure goals, and pharmacotherapy: a scientific statement from the American Heart Association","volume":"79","author":"Garovic","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.preghy.2026.101461_b0030","unstructured":"World Health Organization. WHO technical specifications for automated non-invasive blood pressure measuring devices with cuff. World Health Organization. Am J Obstet Gynecol 2022; 2020:1\u201368. https:\/\/www.who.int\/publications\/i\/item\/9789240002654."},{"key":"10.1016\/j.preghy.2026.101461_b0035","doi-asserted-by":"crossref","DOI":"10.1186\/1742-4755-10-S1-S2","article-title":"Born too soon Preterm Birth Action Group: born too soon: the global epidemiology of 15 million preterm births","volume":"10","author":"Blencowe","year":"2013","journal-title":"Reprod. Health"},{"key":"10.1016\/j.preghy.2026.101461_b0040","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1089\/bfm.2017.0236","article-title":"Treating hypertension during breastfeeding","volume":"13","author":"Anderson","year":"2018","journal-title":"Breastfeed. Med."},{"key":"10.1016\/j.preghy.2026.101461_b0045","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/ajh\/hpv134","article-title":"Impact of Antihypertensive Agents on Central Systolic Blood pressure and Augmentation Index: a Meta-analysis","volume":"29","author":"McGaughey","year":"2016","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.preghy.2026.101461_b0050","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1471-0528.1982.tb04659.x","article-title":"A randomized study comparing timolol and methyldopa in-hospital treatment of puerperal hypertension","volume":"89","author":"Fidler","year":"1982","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"10.1016\/j.preghy.2026.101461_b0055","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1055\/s-2007-999634","article-title":"Utilization of hydralazine or alpha-methyldopa for the management of early puerperal hypertension","volume":"6","author":"Griffis","year":"1989","journal-title":"Am. J. Perinatol."},{"key":"10.1016\/j.preghy.2026.101461_b0060","article-title":"Amlodipine versus nifedipine ER for the management of postpartum hypertension: a noninferiority randomized controlled trial","volume":"7","author":"Pratt","year":"2024","journal-title":"Am J Obstet Gynecol MFM"},{"key":"10.1016\/j.preghy.2026.101461_b0065","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1161\/HYPERTENSIONAHA.117.09972","article-title":"Labetalol versus nifedipine as antihypertensive treatment for chronic hypertension in pregnancy: a randomized controlled trial: a randomized controlled trial","volume":"70","author":"Webster","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.preghy.2026.101461_b0070","first-page":"1428","article-title":"Oral labetalol versus oral nifedipine for the management of postpartum hypertension a randomized control trial: Labetolol v\/s nifedipine for Postpartum H\/T: a RCT","volume":"35","author":"Ainuddin","year":"2019","journal-title":"Pak J Med Sci Q"},{"key":"10.1016\/j.preghy.2026.101461_b0075","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1161\/CIRCULATIONAHA.107.704023","article-title":"Ethnic differences in cardiovascular drug response: potential contribution of pharmacogenetics: potential contribution of pharmacogenetics","volume":"118","author":"Johnson","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.preghy.2026.101461_b0080","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0002-9378(99)70314-5","article-title":"A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy","volume":"181","author":"Vermillion","year":"1999","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2026.101461_b0085","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/s41371-023-00841-x","article-title":"Comparing the efficacy of oral labetalol with oral amlodipine in achieving blood pressure control in women with postpartum hypertension: randomized controlled trial (HIPPO study - Hypertension in Pregnancy & P postpartum Oral- antihypertensive therapy)","volume":"37","author":"Gupta","year":"2023","journal-title":"J. Hum. Hypertens."}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778926000498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778926000498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T07:52:50Z","timestamp":1780905170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778926000498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":17,"alternative-id":["S2210778926000498"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2026.101461","relation":{},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of oral amlodipine with oral labetalol in achieving blood pressure control in women with postpartum hypertension \u2013 A randomised control study","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2026.101461","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101461"}}